Search - tctmd.com

Displaying 401 - 411 of 411

Sort: Relevancy | Date

News Daily News

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Michael O'Riordan

June 13, 2016

News Daily News

Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis

Shelley Wood

June 10, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

News Conference News EAS 2016

Good Fats, Bad Fats, and Sugar: A ‘Big Picture’ Approach Is Warranted With Diet Interventions for Cardiovascular Disease

Yael L. Maxwell

May 31, 2016

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

News Daily News

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

Caitlin E. Cox

March 10, 2011

News Daily News

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

L.A. McKeown

January 24, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

Advertisement

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Good Fats, Bad Fats, and Sugar: A ‘Big Picture’ Approach Is Warranted With Diet Interventions for Cardiovascular Disease

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content